WO2003107000A3 - Determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein - Google Patents

Determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein Download PDF

Info

Publication number
WO2003107000A3
WO2003107000A3 PCT/EP2003/006038 EP0306038W WO03107000A3 WO 2003107000 A3 WO2003107000 A3 WO 2003107000A3 EP 0306038 W EP0306038 W EP 0306038W WO 03107000 A3 WO03107000 A3 WO 03107000A3
Authority
WO
WIPO (PCT)
Prior art keywords
reactive protein
interaction
constituents
bind
determining
Prior art date
Application number
PCT/EP2003/006038
Other languages
German (de)
French (fr)
Other versions
WO2003107000A2 (en
Inventor
Aimo Kannt
Antje Pommereau
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Priority to AU2003250344A priority Critical patent/AU2003250344A1/en
Priority to MXPA04012232A priority patent/MXPA04012232A/en
Priority to EP03759923A priority patent/EP1516187A2/en
Priority to CA002489021A priority patent/CA2489021A1/en
Priority to JP2004513768A priority patent/JP2005529348A/en
Priority to BR0311709-0A priority patent/BR0311709A/en
Publication of WO2003107000A2 publication Critical patent/WO2003107000A2/en
Publication of WO2003107000A3 publication Critical patent/WO2003107000A3/en
Priority to NO20050037A priority patent/NO20050037L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to an HTS-capable method and testing system for determining the interaction between a C-reactive protein (CRP) or C1q and constituents that bind to a CRP or C1q in order to determine the concentration of a solution containing CRP or C1q and to identify substances that influence the interaction between CRP or C1q and constituents that bind thereto, particularly the interaction between CRP and C1q.
PCT/EP2003/006038 2002-06-12 2003-06-10 Hts-capable method and testing system for determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein WO2003107000A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2003250344A AU2003250344A1 (en) 2002-06-12 2003-06-10 Determining the interaction between a C-reactive protein and constituents that bind to a C-reactive protein
MXPA04012232A MXPA04012232A (en) 2002-06-12 2003-06-10 Hts-capable method and testing system for determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein.
EP03759923A EP1516187A2 (en) 2002-06-12 2003-06-10 Hts-capable method and testing system for determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein
CA002489021A CA2489021A1 (en) 2002-06-12 2003-06-10 Determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein
JP2004513768A JP2005529348A (en) 2002-06-12 2003-06-10 HTS capable method and test system for measuring the interaction between C-reactive protein and components binding to C-reactive protein
BR0311709-0A BR0311709A (en) 2002-06-12 2003-06-10 Process capable of hts and test system for determining the interaction between c-reactive protein and c-reactive protein binding components
NO20050037A NO20050037L (en) 2002-06-12 2005-01-04 Method capable of HTS and test system to determine the interaction between a C-reactive protein and components that bind to a C-reactive protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226011A DE10226011A1 (en) 2002-06-12 2002-06-12 HTS-capable method and test system for determining the interaction between c-reactive protein and components that bind to C-reactive protein
DE10226011.7 2002-06-12

Publications (2)

Publication Number Publication Date
WO2003107000A2 WO2003107000A2 (en) 2003-12-24
WO2003107000A3 true WO2003107000A3 (en) 2004-05-27

Family

ID=29718976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/006038 WO2003107000A2 (en) 2002-06-12 2003-06-10 Hts-capable method and testing system for determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein

Country Status (14)

Country Link
EP (1) EP1516187A2 (en)
JP (1) JP2005529348A (en)
CN (1) CN1745300A (en)
AR (1) AR040259A1 (en)
AU (1) AU2003250344A1 (en)
BR (1) BR0311709A (en)
CA (1) CA2489021A1 (en)
DE (1) DE10226011A1 (en)
MX (1) MXPA04012232A (en)
NO (1) NO20050037L (en)
RU (1) RU2005100042A (en)
TW (1) TW200411179A (en)
WO (1) WO2003107000A2 (en)
ZA (1) ZA200409199B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102721813A (en) * 2012-07-09 2012-10-10 沃克(天津)生物科技有限公司 Homogeneous luminous immunoassay assay kit for prostate specific antigen and detection method therefor
CN103852465A (en) * 2012-11-30 2014-06-11 通用电气公司 Method and apparatus for detecting marker protein
US20170097339A1 (en) * 2015-10-02 2017-04-06 Tgr Biosciences Pty Ltd. Analyte Detection with Multiple Substrates
CN107976535B (en) * 2017-11-03 2020-03-20 科美诊断技术股份有限公司 Homogeneous immunoassay kit for detecting target IgM antibody in sample and use method and application thereof
CN109752332A (en) * 2017-11-07 2019-05-14 重庆中元汇吉生物技术有限公司 A kind of C1Q detection kit
CN108445238A (en) * 2018-02-11 2018-08-24 北京科美生物技术有限公司 Detect the homogeneous immunological detection reagent suit and its preparation method and application of interstitialcellstimulating hormone (ICSH)
CN108169497A (en) * 2018-02-11 2018-06-15 北京科美生物技术有限公司 Human prolactin detection kit and preparation method and application
CN108445239B (en) * 2018-02-11 2021-11-02 科美诊断技术股份有限公司 Homogeneous phase immunoassay reagent kit for detecting beta human chorionic gonadotropin, and preparation method and application thereof
CN108490194A (en) * 2018-02-11 2018-09-04 北京科美生物技术有限公司 Detect the homogeneous immunological detection reagent suit and its preparation method and application of follicular stimulating hormone
CN108445216B (en) * 2018-02-11 2021-10-15 科美诊断技术股份有限公司 Human anti-mullerian hormone determination kit and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633488B2 (en) * 1988-04-04 1993-02-04 Northwestern University Binding of immune complexes by modified forms of c-reactive protein
US6140490A (en) * 1996-02-01 2000-10-31 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of complement system proteins
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
ES2135597T3 (en) * 1993-09-03 1999-11-01 Dade Behring Marburg Gmbh FLUORESCENT IMMUNO ASSAYS OF OXYGEN CHANNELING.
US6303325B1 (en) * 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"AlphascreenTM", PERKINELMER, 2003, XP002272309 *
AGRAWAL A ET AL: "Topology and structure of the C1q-binding site on C-reactive protein.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 15 MAR 2001, vol. 166, no. 6, 15 March 2001 (2001-03-15), pages 3998 - 4004, XP002272307, ISSN: 0022-1767 *
GLICKMAN J FRASER ET AL: "A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors", JOURNAL OF BIOMOLECULAR SCREENING, vol. 7, no. 1, February 2002 (2002-02-01), pages 3 - 10, XP008028213, ISSN: 1087-0571 *
GREPIN C ET AL: "High-throughput screening. Evolution of homogeneous time resolved fluorescence (HTRF) technology for HTS", DRUG DISCOVERY TODAY 01 MAY 2000 UNITED KINGDOM, vol. 5, no. 5, 1 May 2000 (2000-05-01), pages 212 - 214, XP002272308, ISSN: 1359-6446 *
JIANG H ET AL: "Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 146, no. 7, 1 April 1991 (1991-04-01), pages 2324 - 2330, XP002251585, ISSN: 0022-1767 *
SEETHALA R.: "Homogeneous assays", HANDBOOK OF DRUG SCREENING MARCEL DEKKER PUB., - 2001, pages 106 - 128, XP008028242 *

Also Published As

Publication number Publication date
AU2003250344A1 (en) 2003-12-31
CA2489021A1 (en) 2003-12-24
CN1745300A (en) 2006-03-08
WO2003107000A2 (en) 2003-12-24
DE10226011A1 (en) 2004-01-08
RU2005100042A (en) 2006-07-20
MXPA04012232A (en) 2005-02-25
JP2005529348A (en) 2005-09-29
EP1516187A2 (en) 2005-03-23
TW200411179A (en) 2004-07-01
ZA200409199B (en) 2005-05-18
NO20050037L (en) 2005-01-04
BR0311709A (en) 2005-03-15
AR040259A1 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
DE602005013957D1 (en) METHOD FOR PERFORMING FULL BLOOD TESTS
DK1098658T3 (en) Manipulated proteins for detecting analytes
DK0820522T3 (en) Assays and devices for detecting extrahepatic biliary atresia
DK1502102T3 (en) Compounds and Methods for Analyzing the Proteome
WO2004063704A3 (en) Vitamin d assay
ATE431853T1 (en) BIO-BAR CODES BASED ON OLIGONUCLEOTIDE-MODIFIED PARTICLES
IS7611A (en) Microprocessor and method for performing a multiplicity of multiples of single microprocessor samples
EP1687283A4 (en) Method and composition useful for determining fk 506
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
DE60110256D1 (en) METHOD FOR CONCENTRATING ANALYTES IN SAMPLES
WO2003107000A3 (en) Determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein
CY1105025T1 (en) LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION
FI990992A0 (en) Procedure for determining the risk of peptic ulcer
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
DE60315715D1 (en) USE OF NICOTINAMIDE N-METHYLTRANSFERASE FOR THE DIAGNOSIS OF COLORECTAL CANCER
WO2001079541A3 (en) Improvements in and relating to analysis of dna samples
ATE547161T1 (en) METHOD FOR THE QUANTITATIVE DETERMINATION OF POLOXAMERES
ATE221657T1 (en) DISTURBANCE BY RHEUMA FACTORS
ATE197507T1 (en) METHOD AND CONNECTIONS FOR DETECTING ANALYTES USING REMANENCE MEASUREMENT AND THE USE THEREOF
DE50105263D1 (en) METHOD FOR THE ANALYSIS OF PROTEINS
ATE520028T1 (en) TEST FOR DETECTING PROTEIN BINDING
DK1386160T3 (en) Method for detecting blood cell antigens and antibodies directed against them
WO2003098182A3 (en) Method for quantifying molecules
ATE340998T1 (en) METHOD FOR DETERMINING VOLATILE SUBSTANCES IN SOLUTION
DE50300480D1 (en) Method for testing the hormonal effect of substances

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004/09199

Country of ref document: ZA

Ref document number: 200409199

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2003759923

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/012232

Country of ref document: MX

Ref document number: 2760/CHENP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2489021

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003250344

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020047020200

Country of ref document: KR

Ref document number: 2004513768

Country of ref document: JP

Ref document number: 2003813442X

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2005100042

Country of ref document: RU

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1020047020200

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003759923

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003759923

Country of ref document: EP